Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in hela cells
Name
Yaffe_Mono-anionic.pdf
Size
845.9 KB
Format
Adobe PDF
Checksum (MD5)
8cd5c909ce2f2568b4e5f29d144d38a5
Author(s) • • • • • • • • •
Qian, Wen-Jian
Park, Jung-Eun
Lai, Christopher C.
Kelley, James A.
Park, Suk-Youl
Lee, Ki Won
Lee, Kyung S.
Burke, Terrence R.
Lim, Daniel Cham-Chin
Yaffe, Michael B
Date Issued
November 2014
Journal
Biopolymers
Publisher
Wiley Blackwell
Citation
Qian, Wen-Jian et al. “Mono-Anionic Phosphopeptides Produced by Unexpected Histidine Alkylation Exhibit High plk1 Polo-Box Domain-Binding Affinities and Enhanced Antiproliferative Effects in Hela Cells: Antiproliferative Effects in HeLa Cells.” Biopolymers 102.6 (2014): 444–455.
Version
Author's final manuscript
Abstract
Binding of polo-like kinase 1 (Plk1) polo-box domains (PBDs) to phosphothreonine (pThr)/phosphoserine (pSer)-containing sequences is critical for the proper function of Plk1. Although high-affinity synthetic pThr-containing peptides provide starting points for developing PBD-directed inhibitors, to date the efficacy of such peptides in whole cell assays has been poor. This potentially reflects limited cell membrane permeability arising, in part, from the di-anionic nature of the phosphoryl group or its mimetics. In our current article we report the unanticipated on-resin N(τ)-alkylation of histidine residues already bearing a N(π)- alkyl group. This resulted in cationic imidazolium-containing pThr peptides, several of which exhibit single-digit nanomolar PBD-binding affinities in extracellular assays and improved antimitotic efficacies in intact cells. We enhanced the cellular efficacies of these peptides further by applying bio-reversible pivaloyloxymethyl (POM) phosphoryl protection. New structural insights presented in our current study, including the potential utility of intramolecular charge masking, may be useful for the further development of PBD-binding peptides and peptide mimetics.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Biology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1002/bip.22569